BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 2, 1999
View Archived Issues
Oral interferon to enter human trials for MS
Read More
Orion signs licensing agreement with R.P. Scherer for Zydis apomorphine
Read More
Clinical study of La Jolla's lupus drug expanded to Europe and Canada
Read More
LeukoSite and Medarex expand HuMab-Mouse licensing agreement
Read More
MedImmune and Ixsys form alliance for monoclonal antibody development
Read More
Onyx and Bayer select lead ras-inhibiting compound
Read More
Emisphere Technologies updates oral heparin development program
Read More
ImmunoGen discusses progress of tumor-activated prodrugs
Read More
Reticulose inhibits CCR5 receptor
Read More
Rosetta completes merger with Acacia
Read More
New MMP and/or TNF production inhibitors developed by Pfizer research group
Read More
ADIR patents new ellipticine/olivacine derivatives with excellent antitumor activity
Read More
AHP describes new dopamine autoreceptor agonists in patent literature
Read More
Agents for diabetes, impotence, lipid and cardiovascular disorders from Fujisawa
Read More
Cysteine protease-inhibitory peptides disclosed by Takeda
Read More
Naturally occurring inhibitors of cathepsins discovered at Sankyo
Read More
Novel therapy for HIV/AIDS to enter clinical trials in the U.S.
Read More
Favorable phase I results reported for GT-2331 as single doses
Read More
Rebetol combination therapy recommended for approval in E.U.
Read More
Chirocaine considered approvable by FDA, rights return to Chiroscience
Read More
German launch announced for Merck's migraine drug
Read More
SuperGen files sNDA for Nipent in mature T-cell malignancies
Read More
New merger in the making: Gilead and NeXstar
Read More
HMN-1108: new small-molecule compound specific for nNOS
Read More
Betathine approved for accelerated phase I/II trials in Canada
Read More
Corvas reacquires rights to injectable anticoagulant from Schering-Plough
Read More
Inodilating agents available for licensing from BTG
Read More